145 related articles for article (PubMed ID: 38483140)
1. Dynamic lymphocyte-CRP ratio as a predictor: a single-centre retrospective study on disease severity and progression in adult COVID-19 patients.
Wang D; Gao Y; Lai QQ; Wu D; Liu HY; Meng H; Wang XT; Tang YJ; Xu JX; Zhang JN; Liu BW; Zhang JN; Fei DS; Kang K
J Int Med Res; 2024 Mar; 52(3):3000605241236278. PubMed ID: 38483140
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission.
Zhang JN; Gao Y; Wang XT; Li NN; Du X; Tang YJ; Lai QQ; Chen PF; Yue CS; Wu JH; Kang K; Zhao MY
Front Immunol; 2022; 13():957407. PubMed ID: 36248811
[TBL] [Abstract][Full Text] [Related]
3. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between the early dynamic changes of lymphocyte and severity of disease in coronavirus disease 2019 patients].
Zhou J; Zhou Y; Cai J; Lin S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):922-926. PubMed ID: 34590557
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].
Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B
Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
[TBL] [Abstract][Full Text] [Related]
9. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
10. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
[TBL] [Abstract][Full Text] [Related]
11. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
12. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
[TBL] [Abstract][Full Text] [Related]
13. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Xu Y; Qian Y; Gu Q; Tang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte-to-C-Reactive Protein (LCR) Ratio Is Not Accurate to Predict Severity and Mortality in Patients with COVID-19 Admitted to the ED.
Abensur Vuillaume L; Lefebvre F; Benhamed A; Schnee A; Hoffmann M; Godoy Falcao F; Haber N; Sabah J; Lavoignet CE; Le Borgne P;
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983064
[TBL] [Abstract][Full Text] [Related]
16. Nutritional biomarkers as predictors of clinical outcomes between COVID-19 severity groups in a tertiary government hospital.
Anzo FM; Buan-Mayo M
Clin Nutr ESPEN; 2023 Feb; 53():134-143. PubMed ID: 36657905
[TBL] [Abstract][Full Text] [Related]
17. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients.
Erdogan A; Can FE; Gönüllü H
J Med Virol; 2021 Sep; 93(9):5555-5559. PubMed ID: 34019701
[TBL] [Abstract][Full Text] [Related]
19. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
[TBL] [Abstract][Full Text] [Related]
20. The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19.
Baran B; Yetkin NA; Tutar N; Türe Z; Oymak FS; Gülmez İ
Cureus; 2024 Jan; 16(1):e51458. PubMed ID: 38298278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
